Veterinary Medicines

Suivac APP emulsion for injection for pigs

Authorised
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
Download as PDF

Product identification

Medicine name:
Suivac APP emulsion for injection for pigs
Suivac APP vet. injeksjonsvæske, emulsjon til svin.
Active substance:
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, APX II toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX III toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX III toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX I toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX I toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX I toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX III toxoid
    1.00
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • 100 ml (50 doses) vial in a cardboard box
  • 50 ml (25 doses) vial in a cardboard box
  • 500 ml (250 doses) vial in a cardboard box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chemvet DK A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 16-11163
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0119/001
Concerned member states:
  • Austria
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Norway
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 27/01/2022
Download

PI.pdf

English (PDF)
Published on: 27/01/2022
Download